Financials Lophos Holdings Inc.

Equities

MESC

CA5439371066

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange 16:39:29 24/05/2024 BST 5-day change 1st Jan Change
0.05 CAD -9.09% Intraday chart for Lophos Holdings Inc. -9.09% +25.00%

Income Statement Evolution (Annual data)

Fiscal Period: March 2022 2023
Net sales - -
EBITDA 1 -0.5017 -0.7613
EBIT 1 -0.5119 -0.8014
Operating Margin - -
Earnings before Tax (EBT) 1 -0.5664 -0.9877
Net income 1 -0.5664 -0.9877
Net margin - -
EPS 2 -0.0264 -0.0149
Free Cash Flow - -0.5977
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 15/08/23 02/09/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2022 2023
Net Debt 1 1.01 1.92
Net Cash position 1 - -
Leverage (Debt/EBITDA) -2.017 x -2.52 x
Free Cash Flow - -0.6
ROE (net income / shareholders' equity) - -53.4%
ROA (Net income/ Total Assets) - -11.7%
Assets 1 - 8.424
Book Value Per Share 2 0.0300 0.0200
Cash Flow per Share 2 0.0100 0
Capex 1 0.75 0.03
Capex / Sales - -
Announcement Date 15/08/23 02/09/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. MESC Stock
  4. Financials Lophos Holdings Inc.